Home World News 177Lu-DOTATATE Shows Promising Efficacy in the Treatment of Patients with Progressive Metastatic... World News 177Lu-DOTATATE Shows Promising Efficacy in the Treatment of Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas By Ogkologos - September 2, 2025 288 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the Phase II study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients... March 18, 2026 Oncogenic Drivers Associated with Late Recurrence in Postmenopausal Women with ER-positive/HER2-negative... July 10, 2020 ScottishPower help us shine a light on air pollution and cancer December 9, 2021 FDA Approves Pembrolizumab with Chemotherapy for Unresectable Advanced or Metastatic Malignant... September 19, 2024 Load more HOT NEWS What to Know About Biomarker Testing for Lung Cancer: An Expert... Adding Atezolizumab to First-Line Bevacizumab Plus Platinum Regimen Improves Survival in... 15% of People With Lung Cancer Have an Inherited Mutation for... Sublobar Resection Noninferior to Lobectomy in Terms of DFS Among Patients...
